Allyx Therapeutics, Inc.
4 private offerings reported to the SEC on Form D since 2016, $41.1M sold in all. Biotech, Connecticut.
- Form D offerings: 4
- Reported sold: $41.1M
- Newest: May 11, 2026
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| May 11, 2026 | — | $27.9M | $30.0M | Allyx Therapeutics, Inc.Biotech · Connecticut | Oct 21, 2026 | 0001865257-26-000004 |
| Mar 3, 2026 | — | $3.3M | $4.0M | Allyx Therapeutics, Inc.Biotech · Connecticut | Not amended | 0001865257-26-000003 |
| Feb 10, 2023 | — | $2.3M | $2.3M | Allyx Therapeutics, Inc.Biotech · Connecticut | Not amended | 0001865257-23-000001 |
| Jun 2, 2021 | — | $7.6M | $8.0M | Allyx Therapeutics, Inc.Biotech · Connecticut | Not amended | 0001865257-21-000001 |
- Business address
- New Haven, CT
- Incorporated in
- Delaware
- All SEC filings
- CIK 1865257 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR